Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

HHS issues conflict of interest draft guidance: "1Financial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection" recommends taking measures such as separating responsibility for financial and research decisions and establishing CoI committees to verify the absence of financial interests. Aimed at individuals and organizations engaged in human subjects research, the March 31 guidance provides points to consider and aligns with December 2001 GAO recommendations calling on HHS to develop best practices for managing investigator and institutional financial CoI in biomedical research. Comments on the guidance are due by May 30...

You may also be interested in...



Optometrists, Legislators Push For Stronger FDA Oversight Of Contact Lenses

Legislation addressing the regulation of decorative contact lenses has a strong chance of being considered this fall when Congress returns from its August recess, according to staffers

Optometrists, Legislators Push For Stronger FDA Oversight Of Contact Lenses

Legislation addressing the regulation of decorative contact lenses has a strong chance of being considered this fall when Congress returns from its August recess, according to staffers

Financial Conflict In Trials Should Be Ignored In Complex Cases – AdvaMed

Medical technology inventors should be permitted to participate as clinical trial investigators provided their interests are disclosed beforehand, AdvaMed claims in comments to an HHS proposal regulating financial conflict of interests in medical studies

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018170

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel